Ostrum Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Ostrum Asset Management's JNJ Position: Q2 2026 in Review
Ostrum Asset Management increased its Johnson & Johnson (JNJ) stake by 0.86% in Q2 2026, buying an estimated $111K and bringing the position to 55,737 shares worth $14.2M. The position accounts for 0.68% of the portfolio, ranked #29.
Ostrum Asset Management first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.8M in Q4 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ostrum Asset Management held 55,737 shares of Johnson & Johnson worth $14.2M as of Q2 2026.
- Ostrum Asset Management bought 475 Johnson & Johnson shares in Q2 2026, an estimated $111K.
- Johnson & Johnson made up 0.68% of Ostrum Asset Management's portfolio in Q2 2026, its #29 holding.
- Ostrum Asset Management first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
- Ostrum Asset Management's Johnson & Johnson position peaked at $14.8M in Q4 2025.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.